Efficacy of High‐Dose Intravenous Anakinra in Pediatric TAFRO Syndrome: Report of Two Cases and Literature Review
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.31759 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Serena Palmeri und 10 weiteren Autor:innen. Beteiligte Einrichtung: UOC Rheumatology and Autoinflammatory diseases, IRCCS Istituto Giannina Gaslini, Genoa, Italy. Hauptthemen laut MEDLINE: Interleukin 1 Receptor Antagonist Protein, Castleman Disease, Fever, Thrombocytopenia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
TAFRO (thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly) syndrome is a rare, life‐threatening inflammatory condition linked to infections, neoplasms, and idiopathic multicentric Castleman disease. Interleukin (IL)‐6 inhibitors are the primary treatment, but refractory cases require alternatives. This study reports the first two pediatric TAFRO cases successfully treated with anakinra, an IL‐1 receptor antagonist. Both patients had severe, rapidly progressing disease with multiorgan involvement. Anakinra, combined with corticosteroids, led to significant improvement and remission. We provide a literature review of pediatric TAFRO, confirming its rarity and the partial efficacy of IL‐6 inhibitors in many cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UOC Rheumatology and Autoinflammatory diseases, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
- Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
- UOC Pathology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
- UOC Oncology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
- Department of Integrated Surgical and Diagnostic Sciences (DISC), University of Genoa, Genoa, Italy.
ORCID-Profile: Serena Palmeri, Jacopo Ferro, Valentina Natoli, Caterina Matucci-Cerinic, Silvia Rosina, Stefano Volpi, Valerio Gaetano Vellone, Marco Gattorno, Roberta Caorsi
Zitieren
APA
Palmeri, S., Ferro, J., Natoli, V., Matucci-Cerinic, C., Papa, R., Rosina, S., Sorrentino, S., Volpi, S., Vellone, V. G., Gattorno, M., & Caorsi, R. (2025). Efficacy of High‐Dose Intravenous Anakinra in Pediatric TAFRO Syndrome: Report of Two Cases and Literature Review. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31759
Vancouver
Palmeri S, Ferro J, Natoli V, Matucci-Cerinic C, Papa R, Rosina S, et al. Efficacy of High‐Dose Intravenous Anakinra in Pediatric TAFRO Syndrome: Report of Two Cases and Literature Review. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31759
BibTeX
@article{Palmeri2025,
author = {Palmeri, Serena and Ferro, Jacopo and Natoli, Valentina and Matucci-Cerinic, Caterina and Papa, Riccardo and Rosina, Silvia and Sorrentino, Stefania and Volpi, Stefano and Vellone, Valerio Gaetano and Gattorno, Marco and Caorsi, Roberta},
title = {Efficacy of High‐Dose Intravenous Anakinra in Pediatric TAFRO Syndrome: Report of Two Cases and Literature Review},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.31759}
}
EUVIMED